Advertisement

Topics

Latest "Medicare Diabetes Screening Project" News Stories

04:02 EDT 25th September 2018 | BioPortfolio

Here are the most relevant search results for "Medicare Diabetes Screening Project" found in our extensive news archives from over 250 global news sources.

More Information about Medicare Diabetes Screening Project on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Medicare Diabetes Screening Project for you to read. Along with our medical data and news we also list Medicare Diabetes Screening Project Clinical Trials, which are updated daily. BioPortfolio also has a large database of Medicare Diabetes Screening Project Companies for you to search.

Showing "Medicare Diabetes Screening Project" News Articles 1–25 of 9,900+

Tuesday 25th September 2018

Rubicon Genomics Inc Medical Equipment Deals and Alliances Profile [Report Updated: 18072018] Prices from USD $250

SummaryRubicon Genomics Inc Rubicon Genomics, a subsidiary of the Takara Bio Group is a provider of preanalytical amplification technologies. The company offers various types of kits for whole genome sequencing WGS, whole exome sequencing WES, targeted sequencing, copy number variation CNV analysis, Aneuploidy, circulating tumor deoxyribose nucleic acid ctDNA analysis, and gene expression analysis...


Monday 24th September 2018

Big-data project aims to transform farming in world's poorest countries

Genome-wide screening of NEAT1 regulators reveals cross-regulation between paraspeckles and mitochondria


Artificial intelligence to improve drug combination design & personalized medicine

(SLAS (Society for Laboratory Automation and Screening)) A new auto-commentary looks at how an emerging area of artificial intelligence, specifically the analysis of small systems-of-interest specific datasets, can be used to improve drug development and personalized medicine.

AstraZeneca heart study delivers mixed results for diabetes drug

The pharma hopes the results will help Farxiga compete with Eli Lilly and Boehringer Ingelheim's rival Jardiance, which has carved out a leading position on the strength of its heart claims.

Smile Brands Inc. Honored As Gold Stevie® Award Winner in 2018 Stevie Awards for Great Employers

Winners Were Announced on September 21 in New York IRVINE, Calif. (PRWEB) September 24, 2018 Smile Brands Inc. was named the winner of two Gold Stevie® Awards in the categories of Employer of the Year and People-Focused CEO of the Year in the third annual Stevie Awards for Great Employers. The Stevie Awards for Great Employers recognize the world’s best employers and the human resources pr...

Tilray® to Supply More Critically Ill Children in Australia with Medical Cannabis

Tilray CBD 100 Product Successfully Exported to Victoria, Australia and Will Be Supplied to Additional Pediatric Patients Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis production and distribution, today announced that it has successfully exported medical cannabis from Canada to Australia to distribute to critically ill children....

PhRMA’s been trying all year to get Congress to relieve the industry of some of its responsibility for certain Medicare drug costs. It just lost again. https://buff.ly/2NyO3D4 

PhRMA’s been trying all year to get Congress to relieve the industry of some of its responsibility for certain Medicare drug costs. It just lost again. https://buff.ly/2NyO3D4 

Global Orthotic Foot Insoles Market 2018-2022| Penetration of 3D Printing to Spur Growth| Technavio

The global orthotic foot insoles market 2018-2022 is expected to post a CAGR of close to 6% during the forecast period, according to the latest market research report by Technavio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180924005933/en/

Diabetic Retinopathy - A Drug Pipeline Analysis Report by Technavio

Technavio has announced their latest drug pipeline analysis report on diabetic retinopathy. The report includes a comprehensive research on the pipeline molecules under investigation by the pharmaceutical companies within the defined data collection period for the treatment of dia

Hope or hype? Screening practices and the extent of collaboration with mental health providers vary widely from one ketamine clinic to the next, STAT finds. https://buff.ly/2DtcIo6 pic.twitter.com/CW7Zsrs7e7

Hope or hype? Screening practices and the extent of collaboration with mental health providers vary widely from one ketamine clinic to the next, STAT finds. https://buff.ly/2DtcIo6  pic.twitter.com/CW7Zsrs7e7

Participation Up With Online Diabetes Prevention Program

MONDAY, Sept. 24, 2018 -- For overweight/obese veterans with prediabetes, participation is higher for online Diabetes Prevention Programs (DPPs), but weight loss is similar for online and in-person DPPs, according to a study published online Sept....

St. Joseph’s Medical Center Partners with Dynafios to Launch Comprehensive Orthopedic and Spine Program

Central California Hospital Renews Dynafios Physician Alignment Program to Further Enhance the Patient Experience SEATTLE (PRWEB) September 24, 2018 Dynafios, a leading analytics and healthcare consulting company revolutionizing the business of healthcare, is pleased to announce that St. Joseph’s Medical Center successfully launched a new edge-to-edge patient focused Orthopedic and Spine Progra...

These are the digital health startups competing in the MedCity INVEST Twin Cities Pitch Perfect contest

Startups running the gamut from physical therapy to diabetes care to anonymous peer-coaching will compete in the MedCity INVEST Twin Cities Pitch Perfect startup contest on Oct. 11 in Minneapolis.

Anthem Blue Cross Blue Shield Rated Among Top Health Plans in Maine by NCQA

Anthem Blue Cross and Blue Shield in Maine received a rating of 4.5 out of 5 in the recently released National Committee for Quality Assurance (NCQA) Private Health Insurance Plan Ratings 2017-2018, making it a top-ranked plan in the state. The NCQA, a nonprofit organization dedicated to improving health care quality, publicly released its 2018-19...

Congress won’t include PhRMA-backed Medicare change in opioids package

PhRMA’s been trying all year to get Congress to relieve the industry of some of its responsibility for certain Medicare drug costs. It just lost again.

GENFIT: Gearing Up for 2019 with Organizational Changes

GENFIT: Gearing Up for 2019 with Organizational Changes Lille (France), Cambridge (Massachusetts, United States), September 24, 2018 - GENFIT (Euronext: GNFT - ISIN: FR0004163111) today announces some key leadership changes to accompany GENFIT into the next stage of its development and its evolution from an R&D biotechnology company to a fully-integrated biopharmaceutical compan...

Three New Leaders Join AHIP Senior Executive Team

America’s Health Insurance Plans (AHIP) has added three new leaders to its executive team. These leaders further expand AHIP’s deep bench of policy, advocacy, strategy, and operational experts who are committed to health care solutions that work to improve affordability, choice, and value for all Americans: Keith Fontenot joins as Exe...

American Academy of Hospice and Palliative Medicine Receives $5.5 Million to Develop Measures for Community-Based Palliative Care

The American Academy of Hospice and Palliative Medicine (AAHPM) in partnership with the National Coalition for Hospice and Palliative Care (Coalition) and the RAND Corporation, was awarded a

Survey: Nearly One-Third of Seniors Don’t Feel Socially Engaged

Humana Launches Programming to Encourage Socialization, Group Activity during Active Aging Week New findings from leading health and well-being company Humana Inc. (NYSE: HUM) show that nearly one-third (31 percent) of Americans aged 65 and older say they don’t feel socially engaged. However, a majority of respondents say it is important to establish...

Novartis Announces Five Grant Recipients of Excellence in Ophthalmology Vision Award (Xova) for Nonprofit Sustainable Eye Health Initiatives

SOURCE: Novartis SUMMARY:A panel of independent ophthalmologists and optometrists selected five winners out of more than 100 entries from 34 countries  The 2018 grants support initiatives ranging from training teachers for vision screening in schools to launching eye care-specific training modules in Ethiopia, India, Micronesia, Sudan and Zimbabwe  Novartis has been running this program for the ...

AstraZeneca diabetes drug study could give it an edge over competitors

AstraZeneca reported positive results from a major study investigating the heart-protecting benefits of its diabetes drug, Farxiga.

Transgene Unveils myvacTM, an Individualized Immunotherapy against Solid Tumors

myvacTM is a viral vector-based, individualized immunotherapy that has been developed to target solid tumors myvacTM stimulates the patient’s immune system to recognize and destroy tumors using their own cancer specific genetic mutations myvacTM is a highly innovative approach that combines the use of...

AstraZeneca’s Diabetes Drug Farxiga Decreases Risk of Cardiovascular Disease http://dlvr.it/QlCgrG pic.twitter.com/QQCQJ4DIqB

AstraZeneca’s Diabetes Drug Farxiga Decreases Risk of Cardiovascular Disease http://dlvr.it/QlCgrG  pic.twitter.com/QQCQJ4DIqB

Community Health Plan of Washington Partners with National Committee for Quality Assurance to Enhance Care Outcomes

CHPW is one of only four plans selected across the country to participate in demonstration to better understand effectiveness of patient-centered care management. Community Health Plan of Washington (CHPW), Washington’s only not-for-profit health plan offering managed care to Apple Health and Medicare members, today announced an effort in


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks